Table of Content


Introduction
Attention Deficit Hyperactivity Disorder (ADHD) - Overview
Attention Deficit Hyperactivity Disorder (ADHD) - Therapeutics Development
Attention Deficit Hyperactivity Disorder (ADHD) - Therapeutics Assessment
Attention Deficit Hyperactivity Disorder (ADHD) - Companies Involved in Therapeutics Development
Attention Deficit Hyperactivity Disorder (ADHD) - Drug Profiles
Attention Deficit Hyperactivity Disorder (ADHD) - Dormant Projects
Attention Deficit Hyperactivity Disorder (ADHD) - Discontinued Products
Attention Deficit Hyperactivity Disorder (ADHD) - Product Development Milestones
Appendix



List of Figures


Number of Products under Development for Attention Deficit Hyperactivity Disorder (ADHD), H1 2020
Number of Products under Development by Companies, H1 2020
Number of Products under Development by Universities/Institutes, H1 2020
Number of Products by Top 10 Targets, H1 2020
Number of Products by Stage and Top 10 Targets, H1 2020
Number of Products by Top 10 Mechanism of Actions, H1 2020
Number of Products by Stage and Top 10 Mechanism of Actions, H1 2020
Number of Products by Routes of Administration, H1 2020
Number of Products by Stage and Routes of Administration, H1 2020
Number of Products by Molecule Types, H1 2020
Number of Products by Stage and Molecule Types, H1 2020


List of Tables


Number of Products under Development for Attention Deficit Hyperactivity Disorder (ADHD), H1 2020
Number of Products under Development by Companies, H1 2020
Number of Products under Development by Companies, H1 2020 (Contd..1), H1 2020
Number of Products under Development by Universities/Institutes, H1 2020
Products under Development by Companies, H1 2020
Products under Development by Companies, H1 2020 (Contd..1), H1 2020
Products under Development by Companies, H1 2020 (Contd..2), H1 2020
Products under Development by Universities/Institutes, H1 2020
Number of Products by Stage and Target, H1 2020
Number of Products by Stage and Mechanism of Action, H1 2020
Number of Products by Stage and Route of Administration, H1 2020
Number of Products by Stage and Molecule Type, H1 2020
Attention Deficit Hyperactivity Disorder (ADHD) - Pipeline by 4P-Pharma SAS, H1 2020
Attention Deficit Hyperactivity Disorder (ADHD) - Pipeline by AgoneX Biopharmaceuticals Inc, H1 2020
Attention Deficit Hyperactivity Disorder (ADHD) - Pipeline by Altus Formulation Inc, H1 2020
Attention Deficit Hyperactivity Disorder (ADHD) - Pipeline by Amarantus Bioscience Holdings Inc, H1 2020
Attention Deficit Hyperactivity Disorder (ADHD) - Pipeline by Arbor Pharmaceuticals LLC, H1 2020
Attention Deficit Hyperactivity Disorder (ADHD) - Pipeline by Attentive Therapeutics Inc, H1 2020
Attention Deficit Hyperactivity Disorder (ADHD) - Pipeline by Avekshan LLC, H1 2020
Attention Deficit Hyperactivity Disorder (ADHD) - Pipeline by BCWorld Pharm Co Ltd, H1 2020
Attention Deficit Hyperactivity Disorder (ADHD) - Pipeline by Boston Pharmaceuticals Inc, H1 2020
Attention Deficit Hyperactivity Disorder (ADHD) - Pipeline by Cennerv Pharma (S) Pte Ltd, H1 2020
Attention Deficit Hyperactivity Disorder (ADHD) - Pipeline by Cingulate Therapeutics LLC, H1 2020
Attention Deficit Hyperactivity Disorder (ADHD) - Pipeline by Collegium Pharmaceutical Inc, H1 2020
Attention Deficit Hyperactivity Disorder (ADHD) - Pipeline by Curemark LLC, H1 2020
Attention Deficit Hyperactivity Disorder (ADHD) - Pipeline by DD Therapeutics LLC, H1 2020
Attention Deficit Hyperactivity Disorder (ADHD) - Pipeline by DURECT Corp, H1 2020
Attention Deficit Hyperactivity Disorder (ADHD) - Pipeline by Eli Lilly and Co, H1 2020
Attention Deficit Hyperactivity Disorder (ADHD) - Pipeline by EncepHeal Therapeutics Inc, H1 2020
Attention Deficit Hyperactivity Disorder (ADHD) - Pipeline by Ensysce Biosciences Inc, H1 2020
Attention Deficit Hyperactivity Disorder (ADHD) - Pipeline by Highland Therapeutics Inc, H1 2020
Attention Deficit Hyperactivity Disorder (ADHD) - Pipeline by INVENT Pharmaceuticals Inc, H1 2020
Attention Deficit Hyperactivity Disorder (ADHD) - Pipeline by Kashiv BioSciences LLC, H1 2020
Attention Deficit Hyperactivity Disorder (ADHD) - Pipeline by KemPharm Inc, H1 2020
Attention Deficit Hyperactivity Disorder (ADHD) - Pipeline by Limoxifen BV, H1 2020
Attention Deficit Hyperactivity Disorder (ADHD) - Pipeline by Mind Medicine Inc, H1 2020
Attention Deficit Hyperactivity Disorder (ADHD) - Pipeline by NLS Pharma Group, H1 2020
Attention Deficit Hyperactivity Disorder (ADHD) - Pipeline by Noven Pharmaceuticals Inc, H1 2020
Attention Deficit Hyperactivity Disorder (ADHD) - Pipeline by Oryzon Genomics SA, H1 2020
Attention Deficit Hyperactivity Disorder (ADHD) - Pipeline by Otsuka Holdings Co Ltd, H1 2020
Attention Deficit Hyperactivity Disorder (ADHD) - Pipeline by Otsuka Pharmaceutical Co Ltd, H1 2020
Attention Deficit Hyperactivity Disorder (ADHD) - Pipeline by P2D Inc, H1 2020
Attention Deficit Hyperactivity Disorder (ADHD) - Pipeline by RespireRx Pharmaceuticals Inc, H1 2020
Attention Deficit Hyperactivity Disorder (ADHD) - Pipeline by Reviva Pharmaceuticals Inc, H1 2020
Attention Deficit Hyperactivity Disorder (ADHD) - Pipeline by Seropeutics LLC, H1 2020
Attention Deficit Hyperactivity Disorder (ADHD) - Pipeline by Shenox Pharmaceuticals LLC, H1 2020
Attention Deficit Hyperactivity Disorder (ADHD) - Pipeline by Shionogi & Co Ltd, H1 2020
Attention Deficit Hyperactivity Disorder (ADHD) - Pipeline by SK Biopharmaceuticals Co Ltd, H1 2020
Attention Deficit Hyperactivity Disorder (ADHD) - Pipeline by Sunovion Pharmaceuticals Inc, H1 2020
Attention Deficit Hyperactivity Disorder (ADHD) - Pipeline by Supernus Pharmaceuticals Inc, H1 2020
Attention Deficit Hyperactivity Disorder (ADHD) - Pipeline by Suven Life Sciences Ltd, H1 2020
Attention Deficit Hyperactivity Disorder (ADHD) - Pipeline by Taho Pharmaceuticals Ltd, H1 2020
Attention Deficit Hyperactivity Disorder (ADHD) - Pipeline by Terran Biosciences Inc, H1 2020
Attention Deficit Hyperactivity Disorder (ADHD) - Pipeline by Tris Pharma Inc, H1 2020
Attention Deficit Hyperactivity Disorder (ADHD) - Pipeline by Vallon Pharmaceuticals Inc, H1 2020
Attention Deficit Hyperactivity Disorder (ADHD) - Pipeline by Yuyu Pharma Inc, H1 2020
Attention Deficit Hyperactivity Disorder (ADHD) - Dormant Projects, H1 2020
Attention Deficit Hyperactivity Disorder (ADHD) - Dormant Projects, H1 2020 (Contd..1), H1 2020
Attention Deficit Hyperactivity Disorder (ADHD) - Dormant Projects, H1 2020 (Contd..2), H1 2020
Attention Deficit Hyperactivity Disorder (ADHD) - Dormant Projects, H1 2020 (Contd..3), H1 2020
Attention Deficit Hyperactivity Disorder (ADHD) - Dormant Projects, H1 2020 (Contd..4), H1 2020
Attention Deficit Hyperactivity Disorder (ADHD) - Discontinued Products, H1 2020